Portrait
Kenneth Kastaniegaard

Portrait
Kenneth Kastaniegaard

Portrait

Portrait

I co-founded Biogenity in May 2018 while completing my PhD. Since then, it has grown into a successful global contract research organization specializing in Proteomics, Transcriptomics, and Metabolomics.
In addition to commercial success, we actively contribute to the scientific community through participation in two major EU-funded research projects: EXIMIOUS and EXPOSIM.
In June 2024, I co-founded my second venture, Omics Studio, where we are developing software to help researchers analyze and contextualize omics data—specifically in Proteomics, Transcriptomics, and Metabolomics.
The company has already secured pre-seed investment, received soft funding, and entered the market by serving its first customers.
What do you use from your PhD education/training?
With a background in omics, along with strong coding abilities and project management experience.
Did you miss something during your PhD?
Expectation management.
Do you find that a PhD degree is a good starting point for a career outside academia?
Indeed, the required knowledge and skills were critical to success.
Facts about Kenneth Kastaniegaard